chr5-75104328-T-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001372053.1(ANKRD31):āc.5231A>Gā(p.Asn1744Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000141 in 1,537,112 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001372053.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANKRD31 | NM_001372053.1 | c.5231A>G | p.Asn1744Ser | missense_variant | 22/26 | ENST00000506364.6 | NP_001358982.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANKRD31 | ENST00000506364.6 | c.5231A>G | p.Asn1744Ser | missense_variant | 22/26 | 5 | NM_001372053.1 | ENSP00000427262.2 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152202Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000113 AC: 16AN: 141646Hom.: 0 AF XY: 0.000106 AC XY: 8AN XY: 75738
GnomAD4 exome AF: 0.000147 AC: 204AN: 1384910Hom.: 2 Cov.: 31 AF XY: 0.000152 AC XY: 104AN XY: 683376
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152202Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74360
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 21, 2021 | The c.5060A>G (p.N1687S) alteration is located in exon 21 (coding exon 21) of the ANKRD31 gene. This alteration results from a A to G substitution at nucleotide position 5060, causing the asparagine (N) at amino acid position 1687 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at